Isis Pharma (ISIS) Higher Following New Antisense Development Collaboration (BIIB)
Go back to Isis Pharma (ISIS) Higher Following New Antisense Development Collaboration (BIIB)| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 216.78 +2.43 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.35 | 52 Week High | $333.65 | |||
| Open | $217.76 | 52 Week Low | $223.02 | |||
| Day High | $219.12 | P/E | 27.76 | |||
| Day Low | $215.00 | EPS | $7.81 | |||
| Volume | 722,348 | |||||
| Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) | Delayed: 57.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.56 | 52 Week High | $77.80 | |||
| Open | $3.73 | 52 Week Low | $37.38 | |||
| Day High | $57.56 | P/E | N/A | |||
| Day Low | $57.56 | EPS | $-0.35 | |||
| Volume | 15 | |||||
